4.6 Article

The Epidemiological and Molecular Aspects of Influenza H5N1 Viruses at the Human-Animal Interface in Egypt

期刊

PLOS ONE
卷 6, 期 3, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0017730

关键词

-

资金

  1. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200700005C]
  2. American Lebanese Syrian Associated Charities

向作者/读者索取更多资源

With 119 confirmed cases between March 2006 and December 2010, Egypt ranks second among countries reporting human H5N1 influenza virus infections. In 2009-2010, Egypt reported 68 new human cases and became the new epicenter for H5N1 infections. We conducted an epidemiological and molecular analysis in order to better understand the situation in Egypt. The onset of new cases peaked annually during the winter and spring months, with majority of cases reported in the Nile Delta region. Most cases were less than 18 years old (62%) and females (60%). The overall case-fatality rate was 34% and significantly increased by age. There was a significant difference between the case-fatality rates among females and males. We observed a significant drop (p = 0.004) in case fatality rate in 2009 (10%) as compared to higher rates (36%-56%) in other years. Hospitalization within 2 or 3 days after onset of symptoms significantly decreased mortality. Molecular analysis showed that variations do occur among viruses isolated from birds as well as from humans in Egypt, and these mutations were especially noted in 2009 viruses. As the epidemiological profile of Egyptian cases differs from other countries, there is an urgent need to conduct prospective studies to enhance our understanding of incidence, prevalence, and determinants of virulence of human infections with avian H5N1 influenza viruses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Influenza antivirals and their role in pandemic preparedness

Jeremy C. Jones, Hui-Ling Yen, Peter Adams, Kimberly Armstrong, Elena A. Govorkova

Summary: Effective antivirals play a crucial role in the early phase of an influenza pandemic, before vaccines are available. Currently, two classes of antiviral drugs are approved for influenza treatment, but resistance has been observed. Therefore, it is important to develop novel antiviral options that target both the virus and the host. This review explores the drawbacks of current antivirals and ongoing research on new agents or combination therapies to address these limitations.

ANTIVIRAL RESEARCH (2023)

Article Biochemistry & Molecular Biology

Synthesis and Molecular Docking Study of Novel Pyrimidine Derivatives against COVID-19

Zahra M. Alamshany, Reham R. Khattab, Nasser A. Hassan, Ahmed A. El-Sayed, Mohamed A. Tantawy, Ahmed Mostafa, Allam A. Hassan

Summary: A novel series of pyrido[2,3-d]pyrimidines, pyrido[3,2-e][1,3,4]triazolo, and tetrazolo[1,5-c]pyrimidines were synthesized and their structures were elucidated. Molecular docking analysis revealed that compounds 7c, 7d, and 7e exhibited promising antiviral activity against SARS-CoV-2 main protease M(pro) with lower IC50 values compared to the commonly used protease inhibitor Lopinavir. The in silico and in vitro results were consistent.

MOLECULES (2023)

Article Microbiology

Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt

Rabeh El-Shesheny, Yassmin Moatasim, Sara H. Mahmoud, Yi Song, Ahmed El Taweel, Mokhtar Gomaa, Mina Nabil Kamel, Mohamed El Sayes, Ahmed Kandeil, Tommy T. Y. Lam, Pamela P. McKenzie, Richard J. Webby, Ghazi Kayali, Mohamed Ahmed Ali

Summary: This study reports the first detection of highly pathogenic avian influenza H5N1 clade 2.3.4.4b viruses in wild birds and domestic ducks from live bird markets in Egypt. The Egyptian H5N1 virus retained the genomic composition of Eurasian strains and mutations associated with zoonotic potential and pathogenicity were detected. Active surveillance of avian influenza viruses in Egypt is warranted as Egypt is considered a hot spot for the evolution of the influenza virus.

PATHOGENS (2023)

Article Multidisciplinary Sciences

Bioactive Azadirachta indica and Melia azedarach leaves extracts with anti-SARS-CoV-2 and antibacterial activities

Bahaa A. Hemdan, Ahmed Mostafa, Marwa M. Elbatanony, Amal M. El-Feky, Tsvetelina Paunova-Krasteva, Stoyanka Stoitsova, Mohamed Azab El-Liethy, Gamila E. El-Taweel, Mobarak Abu Mraheil

Summary: The leaves of Azadirachta indica L. and Melia azedarach L. have medicinal benefits and exhibit antiviral and antibacterial activities. They showed robust anti-SARS-CoV-2 activity and exhibited broad-spectrum medicinal value.

PLOS ONE (2023)

Article Multidisciplinary Sciences

Rapid evolution of A(H5N1) influenza viruses after intercontinental spread to North America

Ahmed Kandeil, Christopher Patton, Jeremy C. Jones, Trushar Jeevan, Walter N. Harrington, Sanja Trifkovic, Jon P. Seiler, Thomas Fabrizio, Karlie Woodard, Jasmine C. Turner, Jeri-Carol Crumpton, Lance Miller, Adam Rubrum, Jennifer DeBeauchamp, Charles J. Russell, Elena A. Govorkova, Peter Vogel, Mia Kim-Torchetti, Yohannes Berhane, David Stallknecht, Rebecca Poulson, Lisa Kercher, Richard J. Webby

Summary: In 2021, highly pathogenic avian influenza A(H5N1) viruses of clade 2.3.4.4b spread rapidly among wild birds and domestic poultry across Asia, Europe, and Africa, and reached North America. The movement of clade 2.3.4.4b was followed by reassortment with viruses circulating in wild birds in North America, resulting in the emergence of genetically and phenotypically diverse A(H5N1) viruses that cause severe disease with neurological involvement in mammals. The ability of the current A(H5N1) 2.3.4.4b virus lineage to reassort and target the central nervous system highlights the need for coordinated planning to control the spread and evolution of the virus and to mitigate the impact of a potential influenza pandemic.

NATURE COMMUNICATIONS (2023)

Article Microbiology

Genome Analysis of Pseudomonas aeruginosa Strains from Chronically Infected Patients with High Levels of Persister Formation

Amr A. Baiomy, Fathy E. Serry, Ashraf A. Kadry, Galal Yahya, Swapnil Doijad, Ahmed Mostafa, Mobarak Abu Mraheil, Amira M. El-Ganiny

Summary: This study conducted genomic analyses of Pseudomonas aeruginosa persister isolates from chronic human infections, revealing their low metabolic rates, multidrug tolerance, and strong biofilm-forming ability. Whole genome sequencing and phylogenetic analysis showed that these persister isolates belong to a distinct clade with a smaller genome size.

PATHOGENS (2023)

Article Microbiology

Whole-Genome Sequence of a Human Monkeypox Virus Strain Detected in Egypt

Wael H. Roshdy, Rabeh El-Shesheny, Yassmin Moatasim, Mina N. Kamel, Shaymaa Showky, Mokhtar Gomaa, Amel Naguib, Nancy El Guindy, Manal Fahim, Mohamed Khalifa, Ramy Galal, Mohamed Hassany, Ahmed Kandeil, Mohamed A. Ali, Amr Kandeel

Summary: Monkeypox virus has been detected in multiple countries recently. Two cases were reported in Egypt, being a part of an ongoing international outbreak. The whole-genome sequence of a monkeypox virus from the first confirmed case in Egypt was reported, which was fully sequenced on the Illumina platform. Phylogenetic analysis showed that the current monkeypox strain is closely related to clade IIb, responsible for recent multicountry outbreaks.

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2023)

Article Pharmacology & Pharmacy

Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses

Andrei A. Ivashchenko, Jeremy C. Jones, Dmitry O. Shkil, Yan A. Ivanenkov, Philippe Noriel Q. Pascua, Melissa K. Penaflor, Ruben N. Karapetian, Elena A. Govorkova, Alexandre V. Ivachtchenko

Summary: In this study, the efficacy of a new orally-dosed neuraminidase inhibitor (NAI) AV5080 against different subtypes of influenza viruses was examined. AV5080 showed superior in vitro efficacy compared to currently approved NAIs, oseltamivir and zanamivir. However, it exhibited reduced inhibition against certain viral variants, such as NA-E119G and NA-R292K. These findings suggest that AV5080 is a promising orally-dosed NAI.

ANTIVIRAL RESEARCH (2023)

Article Multidisciplinary Sciences

Accelerated evolution of SARS-CoV-2 in free-ranging white-tailed deer

Dillon S. Mcbride, Sofya K. Garushyants, John Franks, Andrew F. Magee, Steven H. Overend, Devra Huey, Amanda M. Williams, Seth A. Faith, Ahmed Kandeil, Sanja Trifkovic, Lance Miller, Trushar Jeevan, Anami Patel, Jacqueline M. Nolting, Michael J. Tonkovich, J. Tyler Genders, Andrew J. Montoney, Kevin Kasnyik, Timothy J. Linder, Sarah N. Bevins, Julianna B. Lenoch, Jeffrey C. Chandler, Thomas J. Deliberto, Eugene V. Koonin, Marc A. Suchard, Philippe Lemey, Richard J. Webby, Martha I. Nelson, Andrew S. Bowman

Summary: Research reveals that SARS-CoV-2 has transmitted multiple times in white-tailed deer, with transmission persisting for 2-8 months and spreading across hundreds of kilometers. The virus evolves three times faster in white-tailed deer compared to humans, driven by different mutational biases and selection pressures. Although no significant phenotypic changes were observed in animal models using white-tailed deer origin viruses, the accelerated evolutionary rate poses serious consequences for humans and livestock.

NATURE COMMUNICATIONS (2023)

Review Immunology

Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution

Ahlam Alasiri, Raya Soltane, Akram Hegazy, Ahmed Magdy Khalil, Sara H. Mahmoud, Ahmed A. Khalil, Luis Martinez-Sobrido, Ahmed Mostafa

Summary: Despite being widespread in wild birds and domestic poultry, human infections with highly pathogenic avian influenza H5Nx viruses have been limited since 1996. Few countries use vaccination as a control strategy, while most rely on culling infected flocks. China and Egypt are the major sites where vaccination has been employed, particularly for clade 2.3.4.4b H5N1 viruses. However, improper implementation of control strategies in Egypt has resulted in continuous outbreaks and virus evolution. Comprehensive surveillance in endemic areas is crucial to understand the public health risk of newly emerging immune-evasive or drug-resistant H5Nx variants.

VACCINES (2023)

Article Microbiology

Detection of Coronaviruses in Bats in Lebanon during 2020

Ahmed Kandeil, Mounir Abi-Said, Rebecca Badra, Rabeh El-Shesheny, Ahmed A. Al-Karmalawy, Radwan Alnajjar, Zumama Khalid, Mina Nabil Kamel, Walid Abi Habib, Jad Abdallah, Vijaykrishna Dhanasekaran, Richard Webby, Ghazi Kayali

Summary: Bats are the main carriers of coronaviruses and play a significant role in the emergence of SARS-CoV and SARS-CoV-2. Recent surveillance in Lebanon detected SARS-CoV-like viruses in bats, with 77 positive samples out of 622 swabs. The study provides new insights into the genetic diversity of bat coronaviruses in this region.

PATHOGENS (2023)

Editorial Material Public, Environmental & Occupational Health

We are underestimating, again, the true burden of H5N1 in humans

Mokhtar Gomaa, Yassmin Moatasim, Ahmed El Taweel, Sara H. Mahmoud, Amira S. El Rifay, Ahmed Kandeil, Pamela P. Mckenzie, Richard J. Webby, Rabeh El-Shesheny, Mohamed Ahmed Ali, Ghazi Kayali

BMJ GLOBAL HEALTH (2023)

Article Microbiology

Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E

Yassmin Moatasim, Omnia Kutkat, Ahmed M. Osman, Mokhtar R. Gomaa, Faten Okda, Mohamed El Sayes, Mina Nabil Kamel, Mohamed Gaballah, Ahmed Mostafa, Rabeh El-Shesheny, Ghazi Kayali, Mohamed A. Ali, Ahmed Kandeil

Summary: The study found potential broad-spectrum inhibitory effects of Hydroxocobalamin and Methylcobalamin against three coronaviruses. Cyanocobalamin selectively affects SARS-CoV-2, while Methylcobalamin shows higher inhibition on SARS-CoV-2 compared to Hydroxocobalamin and Cyanocobalamin. These vitamins may have significant binding affinity to viral-specific cell receptors and proteins, suggesting potential benefits for coronavirus-infected patients.

MICROORGANISMS (2023)

Article Biotechnology & Applied Microbiology

Dual action of epigallocatechin-3-gallate in virus-induced cell Injury

Ahmed Mostafa, Gomaa Mostafa-Hedeab, Hany Abdelfattah Elhady, Esraa Ahmed Mohamed, Abozer Y. Eledrdery, Sager Holyl Alruwaili, Ahmed Mohamed Al-Abd, Abdou Kamal Allayeh

Summary: EGCG, the most abundant polyphenol in green tea, has been shown to have significant antiviral activity against SARS-CoV-2 and HSV-2, as well as wound healing properties. It could potentially be a promising option for slowing down the course of acute cellular damage induced by systemic or topical viral infections.

JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2023)

暂无数据